Rionlon (Tianjin) Pharmaceutical Co.,Ltd. was established in 2013, which is dedicated to the production and sales of pharmaceutical ingredients,food supplements, specialty chemicals, medical devices, and cosmetic ingredients.Its facility for Teprenone is the first one in China,which has been in production. Its capacity is 50 tons annually.The Teprenone API has obtained the registration approval by NMPA in China,with the registration no. Y2020000949.and the Japanese MF registration approva. Our new project for Vitamin K series is under construction, and will be ready to produce in 2025. Rionlon's journey has just started. The continuous innovation and the sincere cooperation has been and will be always driving us forward. You are welcomed to share the future with us together.